Bronchodilators Explained for Medical Students: Beta-2 Agonists, Anticholinergics & Theophylline скачать в хорошем качестве

Bronchodilators Explained for Medical Students: Beta-2 Agonists, Anticholinergics & Theophylline

Master the three classes of bronchodilators in one video. From albuterol to tiotropium to theophylline toxicity — every mechanism, adverse effect, and clinical algorithm you need for your shelf exams and boards, explained the way an attending would teach it at the bedside. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 📚 SOURCES & REFERENCES ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Harrison's Principles of Internal Medicine, 22nd Edition • Beta-2 agonists & bronchodilator mechanisms — pp. 2266–2270 • COPD pharmacotherapy & GOLD algorithms — pp. 2298–2300 • Theophylline pharmacology & toxicity — pp. 397, 419 Clinical Trial Evidence • UPLIFT Trial review — Tashkin, Curr Opin Pulm Med, 2010 Tiotropium in COPD: 4 years, 5,993 patients; reduced exacerbations and hospitalizations PMID: 20019615 | DOI: 10.1097/MCP.0b013e328335df1e • GINA 2019 paradigm shift — Reddel et al., Eur Respir J, 2019 SABA-only treatment no longer recommended for adults/adolescents PMID: 31249014 | DOI: 10.1183/13993003.01046-2019 • GINA 2022 primary care update — Levy et al., NPJ Prim Care Respir Med, 2023 Key practical guidance including ICS/formoterol as preferred reliever PMID: 36754956 | DOI: 10.1038/s41533-023-00330-1 • LABA safety controversy — Lang & Davis, Allergy Asthma Proc, 2007 LABA monotherapy risk; ICS + LABA combination evidence PMID: 17479596 | DOI: 10.2500/aap.2007.28.2980 Guidelines • Global Initiative for Asthma (GINA) 2022/2024 — https://ginasthma.org Key change: Step 1–2 now recommends PRN ICS/formoterol; SABA-only eliminated • Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2024/2025 — https://goldcopd.org Key change: ABE grouping replacing ABCD; Group B → dual bronchodilation first-line ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 🎓 EXAM RELEVANCE ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ This video covers high-yield content for: • USMLE Step 1 (pharmacology — pulmonary) • USMLE Step 2 CK (Internal Medicine — asthma, COPD management) • Internal Medicine, Family Medicine, and Emergency Medicine shelf exams • NBME-style board questions on bronchodilator mechanisms and adverse effects ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ ⏱ TIMESTAMPS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 00:00 — Introduction & Overview 01:15 — The 3 Bronchodilator Classes 02:30 — Beta-2 Agonist Mechanism (cAMP cascade) 04:00 — SABAs, LABAs & Ultra-LABAs (drug comparison) 06:20 — LABA Monotherapy Warning & Safety Trials 07:45 — Beta-2 Adverse Effects (tremor, hypokalemia, lactic acidosis) 09:30 — Muscarinic Antagonists: Mechanism & Physiology 11:00 — SAMAs & LAMAs: Drugs, Dosing, UPLIFT Trial 12:30 — Anticholinergic Adverse Effects & Contraindications 14:00 — Theophylline: Mechanism, PDE Inhibition, Drug Interactions 16:15 — Theophylline Toxicity Triad & Fatal Arrhythmias 17:45 — Board Pearl: Adenosine Failure with Theophylline 18:30 — Clinical Algorithms: GINA 2019 AIR Strategy 20:00 — GOLD 2024: COPD Treatment Groups A/B/E 21:30 — Master Summary Table 22:45 — Wrap-Up ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ ⚠️ DISCLAIMER ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ This video is intended for educational purposes only and does not constitute medical advice. Clinical decisions should always be made in consultation with a qualified healthcare provider and with reference to current clinical guidelines. Drug information and guidelines are subject to change — verify doses, contraindications, and treatment protocols with current sources before clinical application. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ #MedSchool #Bronchodilators #Pharmacology #USMLE #Step1 #Step2CK #Asthma #COPD #Albuterol #Tiotropium #Theophylline #InternalMedicine